发明名称 |
COMPOSITIONS, KITS, AND METHODS FOR THE DIAGNOSIS, PROGNOSIS, MONITORING, TREATMENT AND MODULATION OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND HYPOXIA ASSOCIATED ANGIOGENESIS DISORDERS USING GALECTIN-1 |
摘要 |
The present invention is based, in part, on the discovery that galectin-1 (Gall) plays a role in viral-associated PTLD, e.g., EBV-associated PTLD and hypoxia associated angiogenesis disorders. Accordingly, the invention relates to compositions, kits, and methods for diagnosing, prognosing, monitoring, treating and modulating viral-associated PTLD, e.g., EBV-associated PTLD and hypoxia associated angiogenesis disorders. |
申请公布号 |
WO2011060272(A2) |
申请公布日期 |
2011.05.19 |
申请号 |
WO2010US56547 |
申请日期 |
2010.11.12 |
申请人 |
DANA-FARBER CANCER INSTITUTE, INC.;SHIPP, MARGARET, A.;RABINOVICH, GABRIEL |
发明人 |
SHIPP, MARGARET, A.;RABINOVICH, GABRIEL |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|